These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19894112)

  • 61. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.
    Deprez S; Amant F; Smeets A; Peeters R; Leemans A; Van Hecke W; Verhoeven JS; Christiaens MR; Vandenberghe J; Vandenbulcke M; Sunaert S
    J Clin Oncol; 2012 Jan; 30(3):274-81. PubMed ID: 22184379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy.
    Collins B; Mackenzie J; Tasca GA; Scherling C; Smith A
    J Int Neuropsychol Soc; 2014 Apr; 20(4):370-9. PubMed ID: 24229809
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy.
    Poppelreuter M; Weis J; Bartsch HH
    J Psychosoc Oncol; 2009; 27(2):274-96. PubMed ID: 19337933
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.
    Jansen CE; Cooper BA; Dodd MJ; Miaskowski CA
    Support Care Cancer; 2011 Oct; 19(10):1647-56. PubMed ID: 20820813
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Crit Rev Oncol Hematol; 2010 Nov; 76(2):133-41. PubMed ID: 20036141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
    Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
    Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cognitive, psychosocial, somatic and treatment factors predicting return to work after breast cancer treatment.
    Hedayati E; Johnsson A; Alinaghizadeh H; Schedin A; Nyman H; Albertsson M
    Scand J Caring Sci; 2013 Jun; 27(2):380-7. PubMed ID: 22862138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients.
    Schagen SB; Das E; Vermeulen I
    Psychooncology; 2012 Oct; 21(10):1132-5. PubMed ID: 21769988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
    Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
    Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
    J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
    Fischer B
    Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment.
    Chen X; Li J; Ren J; Hu X; Zhu C; Tian Y; Hu P; Ma H; Yu F; Wang K
    Psychooncology; 2014 Oct; 23(10):1165-71. PubMed ID: 24737580
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Verbal memory in breast cancer patients treated with chemotherapy with doxorubicin and cyclophosphamide.
    Andryszak P; Wiłkość M; Żurawski B; Izdebski P
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28850754
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effects of chemotherapy on cognitive function in a mouse model: a prospective study.
    Winocur G; Henkelman M; Wojtowicz JM; Zhang H; Binns MA; Tannock IF
    Clin Cancer Res; 2012 Jun; 18(11):3112-21. PubMed ID: 22467680
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
    Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
    Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer.
    Hodgson KD; Hutchinson AD; Wilson CJ; Nettelbeck T
    Cancer Treat Rev; 2013 May; 39(3):297-304. PubMed ID: 23219452
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer.
    Dutta V
    J Cancer Res Ther; 2011; 7(3):264-9. PubMed ID: 22044805
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.
    Cheung YT; Chui WK; Chan A
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):99-111. PubMed ID: 22015329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.